These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36122786)

  • 21. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Physical Study of Three Pharmaceutically Active Benzodiazepine Derivatives: Crystalline versus Amorphous State and Crystallization Tendency.
    Valenti S; Barrio M; Negrier P; Romanini M; Macovez R; Tamarit JL
    Mol Pharm; 2021 Apr; 18(4):1819-1832. PubMed ID: 33689364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the Chain Length and Topology of the Acetylated Oligosaccharide on the Crystallization Tendency of Naproxen from Amorphous Binary Mixtures.
    Minecka A; Tarnacka M; Jurkiewicz K; Hachuła B; Wrzalik R; Kamiński K; Paluch M; Kamińska E
    Mol Pharm; 2021 Jan; 18(1):347-358. PubMed ID: 33355470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What Are the Important Factors That Influence API Crystallization in Miscible Amorphous API-Excipient Mixtures during Long-Term Storage in the Glassy State?
    Newman A; Zografi G
    Mol Pharm; 2022 Feb; 19(2):378-391. PubMed ID: 34378939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
    Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
    Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of Annealing in the Close Vicinity of
    Kamińska E; Minecka A; Tarnacka M; Hachuła B; Kamiński K; Paluch M
    Mol Pharm; 2020 Mar; 17(3):990-1000. PubMed ID: 31961694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.
    Kaminska E; Adrjanowicz K; Zakowiecki D; Milanowski B; Tarnacka M; Hawelek L; Dulski M; Pilch J; Smolka W; Kaczmarczyk-Sedlak I; Kaminski K
    Pharm Res; 2014 Oct; 31(10):2887-903. PubMed ID: 24831310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory.
    Donnelly C; Tian Y; Potter C; Jones DS; Andrews GP
    Pharm Res; 2015 Jan; 32(1):167-79. PubMed ID: 25074468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binary Mixtures of Meloxicam and L-Tartaric Acid for Oral Bioavailability Modulation of Pharmaceutical Dosage Forms.
    Macasoi C; Meltzer V; Stanculescu I; Romanitan C; Pincu E
    J Funct Biomater; 2024 Apr; 15(4):. PubMed ID: 38667561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
    Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K
    Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
    Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
    Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-Amorphous Screening for the Solubility Enhancement of Poorly Water-Soluble Mirabegron and Investigation of Their Intermolecular Interactions and Dissolution Behaviors.
    An JH; Lim C; Kiyonga AN; Chung IH; Lee IK; Mo K; Park M; Youn W; Choi WR; Suh YG; Jung K
    Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30189645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moisture-induced phase separation and recrystallization in amorphous solid dispersions.
    Luebbert C; Sadowski G
    Int J Pharm; 2017 Oct; 532(1):635-646. PubMed ID: 28867448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rivaroxaban polymeric amorphous solid dispersions: Moisture-induced thermodynamic phase behavior and intermolecular interactions.
    Kapourani A; Vardaka E; Katopodis K; Kachrimanis K; Barmpalexis P
    Eur J Pharm Biopharm; 2019 Dec; 145():98-112. PubMed ID: 31698042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing Phase Separation of Amorphous Solid Dispersions Containing Imidacloprid.
    Mansuri A; Münzner P; Heermant A; Hänsch S; Feuerbach T; Fischer B; Winck J; Vermeer AWP; Hoheisel W; Böhmer R; Gainaru C; Thommes M
    Mol Pharm; 2023 Apr; 20(4):2080-2093. PubMed ID: 36897219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.